Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter

Abstract

In this preliminary study we measured maximum walking distance and walking time on four consecutive days in 29 patients with clinically stable multiple sclerosis (MS). Patients were included in the study if they could achieve a maximum unaided walking distance of 100 up to 500 m. Our results showed a certain day-to-day variability of maximum walking distance, in some cases meaning changes up to 1.5 points in the expanded disability status scale (EDSS), which could be misinterpreted as a progression of the disease. Simultaneous measurements of maximum walking time showed a similar variability, unlike the mean walking speed which turned out to be more stable. Our results therefore suggest that scoring of MS patients should not be based on one single measurement of the maximum walking distance. The more reliable parameter appears to be the mean walking speed.

Keywords

multiple sclerosis EDSS walking distance endurance walking time disability

Get full access to this article

View all access options for this article.

References

Kurtzke JF. (1983) Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

Noseworthy JH et al. (1990) Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial . Neurology 40: 971-975 .

Kesselring J. (1993) Multiple Sklerose, 2nd edn., Kohl-hammer: Stuttgart .

Sharrack B , Hughes RA. (1997) Reliability of distance estimation by doctors and patients: cross sectional study . BMJ 315: 1652-1654 .

Poser CM et al. (1983) New diagnostic criteria for MS: guidelines for research protocols . Ann Neurol 13: 227-231 .

Wade DT. (1993) Measurement in neurologic rehabilitation . Curr Opin Neurol 6: 778-784 .

Vaney C , Blaurock H , Gattlen B , Meisels C. (1996) Assessing mobility in multiple sclerosis using the Rivermead Mobility Index and gait speed . Clin Rehabil 10: 216-226 .

Collen FM , Wade DT , Bradshaw CM. (1990) Mobility after stroke: reliability of measures of impairment and disability . Int Disabil Stud 12: 6-9 .

Holden MK et al. (1984) Clinical gait assessment in the neurologically impaired: reliability and meaningfulness . Phys Ther 64: 35-40 .

10.

Schwid SR et al. (1997) The measurement of ambulatory impairment in multiple sclerosis . Neurology 49: 1419-1424 .

11.

Thompson AJ , Hobart JC. (1998) Multiple Sclerosis: assessment of disability and disability scales . JNeurol 245: 189-196 .

12.

Willoughby EW , Paty DW. (1988) Scales for rating impairment in multiple sclerosis: a critique . Neurology 38: 1793-1798 .

13.

Lechner-Scott J , Brunnschweiler H , Kappos L. (1995) The Study Steering Committee. Is it possible to achieve cross-cultural European agreement in the assessment of neurological deficits? First experience in the European interferon beta-1b trial for secondary progressive MS . J Neuroimmunol 63 (Suppl 1): 42-42 .

14.

Lienert C et al. (1999) Use of composite scores in the quantification of deterioration in multiple sclerosis . Multiple Sclerosis 5: 220-222 .

15.

Cutter GR et al. (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure . Brain 122: 871-882 .

16.

Fischer JS , Rudick RA , Cutter GR , Reingold SC. (1999) The Multiple Sclerosis Functional measure (MSFC): an integrated approach to MS clinical outcome assessment . Multiple Sclerosis 5: 244-250 .